Make an inquiry
Refer a patient
833 367-6942

We noticed you are on our US page. Want to switch regions? Choose from the options:

UK
AU
ES
GenesisCare - logo
Find a location
Find a doctor
GenesisCare - logo
833 367-6942
Make an inquiry
Refer a patient

We noticed you are on our US page. Want to switch regions? Choose from the options:

UK
AU
ES
Find a location
Find a doctor
Make an inquiry
Refer a patient
833 367-6942
  • Healthcare Professionals
  • Latest research
  • Publications
  • Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancer
20 Jan 2019

Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancer

Written by
Shore Neal D., MD, FACS
Higano CS, Armstrong AJ, Sartor AO, Vogelzang NJ, Kantoff PW, McLeod DG, Pieczonka CM, Penson DF, Vacirca J, Concepcion RS, Tutrone RF, Nordquist LT, Quinn DI, Kassabian V, Scholz MC, Harmon M, Tyler RC, Chang NN, Tang H, Cooperberg MR.
US Genesis Logo

GenesisCare US

About us
COVID-19
Careers

Website policies

Website terms of use
HIPAA notice of privacy practices
Su información. Sus derechos. Nuestras responsabilidades
Notice of non-discrimination
Aviso de No Discriminación
Financial conflict of interest in research
Language assistance services
Privacy policy
Do not sell my personal information
Cookie Preferences

Contact us

Make an inquiry
Request medical records

Media & Social

News Room - What's been happening
Facebook
Twitter
Linkedin
Youtube
Vimeo
Facebook

Copyright © 2023 GenesisCare. All Rights Reserved.